A weekly recap of the latest news about Alzheimer’s and dementia By Staff Blogger/ June, 2019 Alzheimer's Orange County compiles a weekly roundup of the latest news stories and developments about Alzheimer's and dementia to keep you updated on what's happening locally and all around the world. Check out this week's headlines below:
A weekly recap of the latest news about Alzheimer’s and dementia By Staff Blogger/ June, 2019 Alzheimer's Orange County compiles a weekly roundup of the latest news stories and developments about Alzheimer's and dementia to keep you updated on what's happening locally and all around the world. Check out this week's headlines below:
A weekly recap of the latest news about Alzheimer’s and dementia By Staff Blogger/ June, 2019 Alzheimer's Orange County compiles a weekly roundup of the latest news stories and developments about Alzheimer's and dementia to keep you updated on what's happening locally and all around the world. Check out this week's headlines below:
Despite what you may think, there is something you can do By Staff Blogger/ June, 2019 Dementia is a general term for the loss of memory and other cognitive functions commonly seen in older adults, and Alzheimer's disease is its most common cause. Contrary to what many believe, memory loss and dementia-related diseases like Alzheimer’s
By Charles S. Wilcox, Ph.D/ November, 2017 Since the approval of Namenda in 2003, there has not been any new and novel medication approved for the treatment of mild-to-moderate, or moderate-to-severe Alzheimer’s disease. During these subsequent fourteen years, there has
By Dr. Trinh/ November, 2017 There are three main stages of Alzheimer’s progression: the mild stage, the moderate stage, and the severe stage. Prior to these three stages of the disease is a pre-Alzheimer’s stage, called “Mild Cognitive Impairment” (MCI). During MCI, individuals may occasionally experience memory problems which do not affect their activities of
By Dr. Trinh/ November, 2017 In neuroscience research, a new direction in Alzheimer’s clinical trials is to detect the disease early enough to possibly prevent it from progressing. Now, more and more research companies, including Irvine Clinical Research (ICR), are shifting their focus to trying to find and identify Alzheimer’s while symptoms are still mild
